JPWO2023089862A1 - - Google Patents
Info
- Publication number
- JPWO2023089862A1 JPWO2023089862A1 JP2023562123A JP2023562123A JPWO2023089862A1 JP WO2023089862 A1 JPWO2023089862 A1 JP WO2023089862A1 JP 2023562123 A JP2023562123 A JP 2023562123A JP 2023562123 A JP2023562123 A JP 2023562123A JP WO2023089862 A1 JPWO2023089862 A1 JP WO2023089862A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021186784 | 2021-11-17 | ||
| JP2021186784 | 2021-11-17 | ||
| PCT/JP2022/026543 WO2023089862A1 (ja) | 2021-11-17 | 2022-07-04 | タマサキツヅラフジ由来アルカロイド含有製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2023089862A1 true JPWO2023089862A1 (https=) | 2023-05-25 |
| JPWO2023089862A5 JPWO2023089862A5 (https=) | 2024-07-10 |
| JP7804878B2 JP7804878B2 (ja) | 2026-01-23 |
Family
ID=86396581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023562123A Active JP7804878B2 (ja) | 2021-11-17 | 2022-07-04 | タマサキツヅラフジ由来アルカロイド含有製剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240299481A1 (https=) |
| EP (1) | EP4434521A4 (https=) |
| JP (1) | JP7804878B2 (https=) |
| CN (1) | CN118555958A (https=) |
| TW (1) | TW202320775A (https=) |
| WO (1) | WO2023089862A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116253740A (zh) * | 2021-12-10 | 2023-06-13 | 中国科学院上海药物研究所 | 环状双苄基异喹啉类化合物及其制备方法和应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12022553084A1 (en) * | 2020-05-14 | 2024-03-25 | Kowa Co | Novel inhalant |
-
2022
- 2022-07-04 CN CN202280075587.5A patent/CN118555958A/zh active Pending
- 2022-07-04 JP JP2023562123A patent/JP7804878B2/ja active Active
- 2022-07-04 EP EP22895151.3A patent/EP4434521A4/en active Pending
- 2022-07-04 WO PCT/JP2022/026543 patent/WO2023089862A1/ja not_active Ceased
- 2022-08-05 TW TW111129633A patent/TW202320775A/zh unknown
-
2024
- 2024-05-13 US US18/662,946 patent/US20240299481A1/en active Pending
Non-Patent Citations (2)
| Title |
|---|
| HE CHANG-LONG ET AL.: "Identification of bis-benzylisoquinoline alkaloids as SARS-CoV-2 entry inhibitors from a library of", SIGNAL TRANSDUCTION AND TARGETED THERAPY, vol. 6:131, JPN6022040716, 23 March 2021 (2021-03-23), ISSN: 0005578175 * |
| OHASHI H., ET AL.: "Multidrug treatment with nelfinavir and cepharanthine against COVID-19", BIORXIV, JPN6022037242, 2020, ISSN: 0005578174 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20240299481A1 (en) | 2024-09-12 |
| JP7804878B2 (ja) | 2026-01-23 |
| EP4434521A1 (en) | 2024-09-25 |
| TW202320775A (zh) | 2023-06-01 |
| WO2023089862A1 (ja) | 2023-05-25 |
| EP4434521A4 (en) | 2025-11-05 |
| CN118555958A (zh) | 2024-08-27 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240424 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240424 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250422 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20250619 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20250820 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250821 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20250820 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20251202 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20251223 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7804878 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |